5 In-vitro reagents for diagnostic veterinary use; in-vitro reagents for diagnostic medical use; in-vitro diagnostic preparations for medical use; immunoassay reagents for medical use; insulin; genetic identity tests comprised of reagents for medical purposes; chemical test reagents for veterinary use; medical diagnostic test strips; medical diagnostic reagents and assays for testing of body fluids; test strips for measuring blood glucose levels; reagents for use in medical genetic testing; reagents for use in diagnostic tests for medical purposes; cotton swabs for medical purposes; reagents for use in diagnostic tests for veterinary purposes; reagents for use in veterinary genetic testing; chemical test reagents for medical use; reagents for use with analyzers for medical use; reagents for use with analyzers for veterinary purposes; reactants for veterinary diagnosis; swabs for medical use; reagents for medical use; biological indicators for medical diagnosis; indicators for medical diagnosis, namely, biological indicators for monitoring sterilization processes for medical purposes; diagnostic chemical reagents for medical use; reactants for medical diagnosis; diagnostic preparations for medical or veterinary purposes; cotton wool in the form of sticks for medical use; chemical reagents for veterinary use; cellulose wadding for medical purposes; diagnostic substances for medical use; reagents for use in analysis for veterinary purposes; enzymes for medical purposes; reagents for analytical purposes for veterinary purposes; tampons for medical purposes; diagnostic biomarker reagents for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic testing materials, namely, chemical preparations, chemical reagents, test strips, biological indicators for medical use; enzyme preparations for medical purposes; chemical preparations for testing blood for medical purposes; chemical preparations for medical purposes, namely, chemical preparations for medical and veterinary diagnostic purposes; chemical preparations for medical purposes for the treatment of treatment or prophylaxis of the nervous system, drug for treatment orprophylaxis of the endocrine system, drug for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable immune suppressive agents, injectable distinfectant agents, injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorder, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatose, heterozygous familial hypercholesterolemia, diabetic foot syndrome, arterial hypertension or cardiac insufficiency, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis ALS, cerbral insult, brain trauma, cerebral inflammations, or autoimmune encephalitis, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, enthesiopathy, insertion tendinosis, insertion tendinopathy, tendinitis, periarthritis, periathrosis, arthosis, osteoarthritis, fibrosis, renal fibrosis, liver fibrosis, cardiac fibrosis, cardiac valve fibrosis, pulmonary fibrosis, pulmonary cirrhosis, pulmonary sclerosis, cerebral insult, cerebral stroke, apoplectic insult, apoplexia cerebri, ictus apoplecticus, cerebral infarction, brain scars, gliosis, contracture, fibrotendinous contracture, fibrous contracture, joint contracture, tendon contracture, Dupuytren's contracture, Dupuytren's disease, glaucoma, eye pressure elevation, intraocular pressure elevation, primary chronic glaucoma, multiple sclerosis, disseminated demyleinating encephalomyelitis, encephalomyelitis disseminata, encephalitis disseminata, cerebral polysclerosis, amyotrophic lateral sclerosis, myatrophic lateral sclerosis, motoneuron disease, Lou Gehrig's syndrome, postcovid syndrome, longcovid syndrome; cellulose wool for medical use; reagents for analytical purposes for medical purposes; chemical reagents for medical use; enzyme preparations for veterinary purposes; reagent paper for medical or veterinary purposes; impregnated medicated wipes; medicinal preparations and substances, namely, for the treatment or prophylaxis of the nervous system, drug for treatment orprophylaxis of the endocrine system, drug for treatment or prophylaxis of cardiovascular system, injectable pharmaceutical for treatment or prophylaxis of respiratory tract, injectable pharmaceutical for treatment or prophylaxis of gastro intestinal tract, injectable pharmaceutical for treatment or prophylaxis of kidney or urinary tract, injectable pharmaceutical for treatment or prophylaxis of skin, injectable vitamins, injectable antibiotics, injectable synthetic chemotherapeutic agents, injectable antimyotics, injectable pharmaceuticals for treatment or prophylaxis of mycobacteria, injectable pharmaceuticals for treatment or prophylaxis of parasites, injectable pharmaceuticals for treatment or prophylaxis of virus infections, injectable cytokine agents, injectable immune suppressive agents, injectable distinfectant agents, injectable pharmaceuticals for treatment of malignant tumors, injectable pharmaceuticals for treatment or prophylaxis of extracellular matrix, injectable pharmaceutical for treatment or prophylaxis of a hyaluronan-associated and/or proteoglycan-associated disease or disorder, injectable pharmaceutical for treatment or prophylaxis of homozygous familial hypercholesterolemia xanthomatose, heterozygous familial hypercholesterolemia, diabetic foot syndrome, arterial hypertension or cardiac insufficiency, injectable pharmaceutical for treatment or prophylaxis of a neurodegenerative disease associated with an increased cerebral glycosaminoglycan level, injectable pharmaceutical for treatment or prophylaxis of Alzheimer's disease, vascular dementia, Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis ALS, cerbral insult, brain trauma, cerebral inflammations, or autoimmune encephalitis, injectable pharmaceutical for treatment or prophylaxis of radiation disease, injectable pharmaceutical for treatment or prophylaxis of tendovaginitis, enthesiopathy, insertion tendinosis, insertion tendinopathy, tendinitis, periarthritis, periathrosis, arthosis, osteoarthritis, fibrosis, renal fibrosis, liver fibrosis, cardiac fibrosis, cardiac valve fibrosis, pulmonary fibrosis, pulmonary cirrhosis, pulmonary sclerosis, cerebral insult, cerebral stroke, apoplectic insult, apoplexia cerebri, ictus apoplecticus, cerebral infarction, brain scars, gliosis, contracture, fibrotendinous contracture, fibrous contracture, joint contracture, tendon contracture, Dupuytren's contracture, Dupuytren's disease, glaucoma, eye pressure elevation, intraocular pressure elevation, primary chronic glaucoma, multiple sclerosis, disseminated demyleinating encephalomyelitis, encephalomyelitis disseminata, encephalitis disseminata, cerebral polysclerosis, amyotrophic lateral sclerosis, myatrophic lateral sclerosis, motoneuron disease, Lou Gehrig's syndrome, postcovid syndrome, longcovid syndrome; reagents for microbiological analysis for veterinary purposes; impregnated medicated swabs; diagnostic reagents for medical use; enzymes for veterinary purposes; reagents for microbiological analysis for medical purposes; reagent paper for medical purposes; reagent paper for veterinary purposes; capillary stabilizing agents for medical purposes; diagnostic agents for medical use; wadding for medical purposes; dental preparations for disclosing plaque
Trademark: 79310327
